UCB Inc. to spend $2 billion on new Georgia biopharma plant

URLhttps://www.plantservices.com/industry-news/news/5
SourcePlant Services
Date Published03/25/2026

Additional Reshoring Information:

Company/Division name UCB Inc
Parent companyUCB SA/NV
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):330
Year reshoring announced:2026
Domestically, the work will be done:In-house
Capital investment ($):2000
Country(ies) from which reshored:Belgium
City reshored to:Rowen
State(s) reshored to:GA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredbiopharmaceuticals
What domestic positive factors made reshoring more attractive?Skilled workforce availability/training
Find Reshoring Articles